Abstracts tagged "education and rheumatoid arthritis (RA)"

Abstract Number: 360 • 2017 ACR/ARHP Annual Meeting
Evaluation of the Educational Needs in Argentinian Patients with Rheumatoid Arthritis Using the SpENAT Questionnaire
Silvana Karina Pérez¹, Maria Julia Santa Cruz¹, María Alejandra Medina¹, Diana Klajn², Silvia Beatriz Papasidero¹, Jose Angel Caracciolo¹, Gisela Pendón³, Federico Giordano⁴, Dora Pereira⁵, Damaris Alvarez⁶, Valeria Astudillo⁶, Eduardo Kerzberg⁶, Adriana Perez Davila⁷, Analia Bohr⁷, Fernando Melo⁸, Nicolas Lloves⁸, Marta Mamani⁹, Claudia Hartvig¹⁰, Gabriela Sanchez¹⁰, Monica Sacnun¹⁰, Yamila Chichotky¹¹, José Velasco Zamora¹¹, Mariana Benegas¹², Javier Rosa¹³, Maria Victoria Garcia¹⁴, Laura Raiti¹⁵, Vanesa Cruzat¹⁵, Rosana Quintana¹⁶, Bernado Pons-Estel¹⁷, Karin Kirmayr¹⁸, Andrea D'Orazio¹⁹, Cinthya Retamozo²⁰, Olga Romano²¹, Rodolfo Perez-Alamino²¹, María de los Angeles Correa²², Gustavo Citera²³, Oscar Rillo²⁴, María Marta Zalazar²⁴, Ana Carolina Costi²⁵, Mercedes Argentina García²⁵, Graciela Gómez²⁶ and Hernán Maldonado Ficco²⁷, ¹Rheumatology Department, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, ²Research Committee, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, ³Hospital Ricardo Gutierrez, La Plata, Argentina, ⁴Rheumatology Department, Hospital Ricardo Gutierrez, La Plata, Buenos Aires, Argentina, ⁵Rheumatology Department, Hospital Ricardo Gutierrez, Buenos Aires, Argentina, ⁶Rheumatology Department, Hospital Ramos Mejía, Buenos Aires, Argentina, ⁷Rheumatology Department, Hospital de Rehabilitación Manuel Rocca, Buenos Aires, Argentina, ⁸Rheumatology Department, Hospital Rivadavia, Buenos Aires, Argentina, ⁹Rheumatology Department, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ¹⁰Rheumatology Department, Hospital Provincial de Rosario, Santa Fe, Argentina, ¹¹Rheumatology Department, Reumatologia al sur, Buenos Aires, Argentina, ¹²Rheumatology Department, Sanatorio de la Providencia, Buenos Aires, Argentina, ¹³Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, CABA, Argentina, ¹⁴Rheumatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ¹⁵Rheumatology Department, Clinica Bessone, Buenos Aires, Argentina, ¹⁶Rheumatology Department, Sanatorio Parque, Rosario, Santa Fe, Argentina, ¹⁷GLADEL, Rosario, Santa Fe, Argentina, ¹⁸Rheumatology Department, Sanatorio San Carlos, Bariloche, Argentina, ¹⁹Rheumatology Department, Hospital Interzonal Dr. José Penna, Bahia Blanca, Buenos Aires, Argentina, ²⁰Rheumatology Department, Centro Especializado Diabetes y Reumatologia, Salta, Argentina, ²¹Rheumatology Department, Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina, ²²Section Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Buenos Aires, Argentina, ²³Rheumatology Department, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²⁴Rheumatology Department, Hospital General de Agudos Dr. Ignacio Pirovano, Buenos Aires, Argentina, ²⁵Rheumatology Department, Hospital Interzonal General de Agudos Gral. José de San Martín, La Plata, Buenos Aires, Argentina, ²⁶Rheumatology Department, Instituto de Investigaciones Medicas Alfredo Lanari, Buenos Aires, Argentina, ²⁷section of Rheumatology, Clinica Regional del Sud, Córdoba, Argentina, Córdoba, Argentina
Background/Purpose: The SpENAT, a Spanish version of the Educational Needs Assessment Tool, is a self-completed questionnaire that assesses educational needs (ENs) with the purpose of…
Abstract Number: 422 • 2014 ACR/ARHP Annual Meeting
Correlation of RAPID3, DAS28 and CDAI in Disease Activity and Effects of Education Level and Co-Morbid Diseases on This Assesment in RA
Kubilay Sahin¹, Yasar Karaaslan^2,3, Zeynep Ozbalkan¹, Ahmet Omma¹ and Nesibe Yesil¹, ¹Rheumatology, Ankara Numune Education and Research Hospital, Ankara, Turkey, ²Rheumatology, Hitit University, Corum, Turkey, ³Ankara Numune Training and Research Hospital, Ankara, Turkey
Background/Purpose RAPID3 is an activity index based on only the patient's report in RA. It doesn’t require joint counts and it isn’t time consuming. Therefore…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].